FibroGen's total assets for Q4 2024 were $214.53M, a decrease of -18.87% from the previous quarter. FGEN total liabilities were $398.16M for the fiscal quarter, a -14.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.